GlassScriptPhysician profile
Rupesh J Shah
NPI 1912043035
$1,767.27
in general payments reported to CMS, 2019-2025
15 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $197 · 2021: $130 · 2022: $164 · 2023: $143 · 2024: $651 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $951.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $443.58 | 2022-2025 | Watchman Access System, Watchman Flx |
| Novartis Pharmaceuticals Corporation | $225.94 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.83 | 2024 | Jardiance |
| Horizon Therapeutics Plc | $125.00 | 2023 | Krystexxa |
| Lilly USA, LLC | $125.00 | 2025 | Jardiance |
| Amgen INC. | $125.00 | 2024 | Krystexxa |
| Lexicon Pharmaceuticals, INC. | $122.80 | 2024 | Inpefa |
| Glaxosmithkline, LLC. | $97.51 | 2019 | |
| Ekos Corporation | $93.33 | 2019 | |
| Biogen, INC. | $81.28 | 2021 | |
| Eisai INC. | $71.21 | 2021-2022 | |
| Orthofix Medical, INC. | $53.80 | 2020 | |
| Janssen Pharmaceuticals, INC | $33.25 | 2020 | |
| Smith+Nephew, INC. | $18.40 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $18.34 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rupesh Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.